SIH Partners’s Tevogen Inc. Common Stock TVGN Stock Holding History

SIH Partners’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-211	Closed	-$11.4K	–	318
2025 Q1	$11.4K	Buy	+211	New	+$13.9K	﹤0.01%	269

Other funds holding TVGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SIH Partners's TVGN Position: Q2 2025 in Review

SIH Partners sold out of Tevogen Inc. Common Stock (TVGN) in Q2 2025, closing a stake of 211 shares — an estimated $11.4K sold.

SIH Partners first reported a position in TVGN in Q1 2025 and held it in 1 quarter. The position peaked at $11.4K in Q1 2025. 56 funds tracked by Wall St. Rank hold TVGN as of Q2 2025.

SIH Partners reported no remaining Tevogen Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 211 Tevogen Inc. Common Stock shares in Q2 2025, an estimated $11.4K.
SIH Partners first reported a position in Tevogen Inc. Common Stock in Q1 2025 and held it in 1 quarter.
SIH Partners's Tevogen Inc. Common Stock position peaked at $11.4K in Q1 2025.
56 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.